Member Info for HallsWorthy

I completely agree, If you can get away with a lifestyle company as incredibly obvious as this, what is the point of a regulatory body?

Aka BS to distract from the most placed company of the last 100 years. "in discussions with" is literally the lowest form of blag a company can do

13% of the company

20% discount

Back to bed

This is what I mean, seems to suggest fine as long as they don't go over the 30% mandatory offer threshold.

My question is wether they have the same obligation to report at 3% and each percent above

Concert parties in the UK are not inherently illegal in the context of corporate takeovers, but their activities are heavily regulated by the City Code on Takeovers and Mergers (the Takeover Code).

Here's a breakdown:

Concept of Concert Parties:

In a takeover, if several individuals or entities act together to acquire, maintain, or influence control of a target company, they may be considered "acting in concert" and treated as a single entity.

This includes both actual concert parties who actively cooperate and presumed concert parties under specific rules like parent-subsidiary relationships or holding 30% or more of another company's shares.

Regulation of Concert Parties:

The Takeover Code aims to ensure fairness and transparency in takeover transactions.

Rules for concert parties:

They must notify the Takeover Panel if their combined shareholding reaches or crosses certain thresholds (like 30% or 50%).

They may be subject to mandatory offer obligations at specific shareholding levels.

Their trading in the target company's shares can be restricted during sensitive periods of a takeover.

Legality Concerns:

Collaboration on a takeover is not illegal as long as it complies with the Takeover Code's disclosure and trading rules.

However, acting in concert without proper notification or engagement in market manipulation can be illegal and attract sanctions from the Takeover Panel or even legal action.

Therefore, concert parties are not prohibited but must navigate a strict regulatory framework. Failure to comply can lead to legal consequences.

Sounds very plausible and i didnt realise a concert party was not allowed, ill go read up and educate myself

Or multiple entities pick up sub 3% on behalf of the same final bidder

Yeah sure, if he doesn't pop up I'm happy to eff off but that's always been the case

Looks like dire financial position and this froth just serves to cover it up. Amazing one can contest any of the financial troubles the company appear to have

Lol no chance he will, dude is way too weird. Didn't even honour the guy with a response which says it all. Doesn't care for any of you, just himself

Can anyone help me understand the points below? Reads very badly but some still seem bullish so I'm trying to work out the disconnect

3.6m net debt

Large monthly outgoings

Net current liabilities 12-15m

Trade receivables £16m Vs £26 trade payables; £10m shortfall

Negative net assets

What would polb do with it that's any different? They don't have the money to find it eithet

Yes just a contract renewal, business as usual, it was a stupid rise off the back of it, but I guess that says a lot about holders

Haven't updated the numbers since but you get the idea :D

With pleasure, Soundman:

Sikhthetech:

First post on HVO = 25th August 2021

First post content = "I bought some this afternoon as a punt" after a newspaper tip.

Total LSE posts on HVO/ORPH = 150

Total ADVFN posts on HVO/Orph = 900(!)

HVO Share performance:

1 month +26%

6 month +79%

1 year +120%

First Post on main his holding TLY = 2014(!)

TLY performance:

1 month flat

6 month -70%

1 year -86%

10 year -92%

Just take a moment to take in the above.

Think of the sheer number of hours and emotional investment he has put into HVO, posting 450 times in 2023 only to watch it climb 120% last year.

Think of the emotional investment and time it takes for the THOUSANDS (yes really) of posts on TLY over an incredible 10 year investment, only to watch it fall 92% in that time and currently sitting at an all time low.

Think of all the times he brings up past calls and how good they have been but never mentions the share prices movements against him on the main two boards he has posted on for the last 18 months and beyond.

Maybe we just start to see where is bitterness comes from but these stories always start with an ego and end with a portfolio worth zero - holding a stock that relentless falls whilst never acknowledging a problem and simultaneously berating a stock on a long term rise while never buying and the sad thing is we've seen it all a thousand times but it always ends the same

Even little Stt too scared to reply to bear points mentioned below. Do any of the holders here actually know how to read accounts

Lol chill strictly, just look at graphs of TLY and HVO over last year and my post about the days of his life he's wasted posting on here and that's all you need to smile

If the offerer hasn't bought any shares at all in the last year, they can offer pretty much what they like above the share price.

If they have, they have to offer above the highest price they paid for even a single share, over the last year (as we are at years high this doesn't matter right now).

If the board doesn't like an offer they will RNS it and encourage voting against it. Given the boards standing with holders, if they say vote against, it will be voted down.

If the board approve the offer, as above, it is likely to be voted through.

The board have all the inside knowledge of past, current and future goings-on so will know better than anybody what 'fair value' is but to us layman it is up to you to decide. Some companies go for a 5% premium, some go for over 100%

Cathal's previous company, Amryt Pharma, sold in Jan2023 at a 107% premium to the previous days close, as per:

https://amrytpharma.com/wp-content/uploads/2023/02/Chiesi-Acquisition-of-Amryt-Scheme-Circular-Final.pdf.

There is nothing to say HVIVO is about to be bought, beyond the current share price action, and theres a good argument against selling at this point just as we are maturing and expanding, but lets see what happens.

Didn't mention specifically increasing margins

The fact our customers paid for our expansion themselves (this has been the biggest indicator of the last couple of years)

Ever increasing offering - new challenge studies being added and expanding scope

Challenge studies now an integral part of fast tracking vaccines during pandemics.

Directors with significant skin in the game

Existing relationships with largest pharma companies and below

I'll add more later

So yet again unable to address any of the points raised bumble? Keep attacking the person but ignoring the argument against is what speaks volumes. Very concerning